These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27453054)

  • 1. Cannabinoid receptor 1 (CNR1) gene variant moderates neural index of cognitive disruption during nicotine withdrawal.
    Evans DE; Sutton SK; Jentink KG; Lin HY; Park JY; Drobes DJ
    Genes Brain Behav; 2016 Sep; 15(7):621-6. PubMed ID: 27453054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical activity differs during nicotine deprivation versus satiation in heavy smokers.
    Evans DE; Sutton SK; Oliver JA; Drobes DJ
    Psychopharmacology (Berl); 2015 Jun; 232(11):1879-85. PubMed ID: 25491928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHRNA5 variants moderate the effect of nicotine deprivation on a neural index of cognitive control.
    Evans DE; MacQueen DA; Jentink KG; Park JY; Lin HY; Drobes DJ
    Genes Brain Behav; 2014 Sep; 13(7):626-32. PubMed ID: 24934182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid receptor 1 gene association with nicotine dependence.
    Chen X; Williamson VS; An SS; Hettema JM; Aggen SH; Neale MC; Kendler KS
    Arch Gen Psychiatry; 2008 Jul; 65(7):816-24. PubMed ID: 18606954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protocadherin gene cluster regulatory variant is associated with nicotine withdrawal and the urge to smoke.
    Jensen KP; Smith AH; Herman AI; Farrer LA; Kranzler HR; Sofuoglu M; Gelernter J
    Mol Psychiatry; 2017 Feb; 22(2):242-249. PubMed ID: 27067016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of CB1 cannabinoid receptor (CNR1) gene polymorphisms with risk for alcohol dependence: Evidence from meta-analyses of genetic and genome-wide association studies.
    Pabalan N; Chaweeborisuit P; Tharabenjasin P; Tasanarong A; Jarjanazi H; Eiamsitrakoon T; Tapanadechopone P
    Medicine (Baltimore); 2021 Oct; 100(43):e27343. PubMed ID: 34713823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation.
    Kubota T; Nakajima-Taniguchi C; Fukuda T; Funamoto M; Maeda M; Tange E; Ueki R; Kawashima K; Hara H; Fujio Y; Azuma J
    Pharmacogenomics J; 2006; 6(2):115-9. PubMed ID: 16402086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of nicotine replacement on cognitive brain activity during smoking withdrawal studied with simultaneous fMRI/EEG.
    Beaver JD; Long CJ; Cole DM; Durcan MJ; Bannon LC; Mishra RG; Matthews PM
    Neuropsychopharmacology; 2011 Aug; 36(9):1792-800. PubMed ID: 21544072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal.
    Ashare RL; Schmidt HD
    Expert Opin Drug Discov; 2014 Jun; 9(6):579-94. PubMed ID: 24707983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
    Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
    J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An assessment of nicotine dependence among pregnant adolescents.
    Albrecht SA; Cornelius MD; Braxter B; Reynolds MD; Stone C; Cassidy B
    J Subst Abuse Treat; 1999 Jun; 16(4):337-44. PubMed ID: 10349607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive effects of very low nicotine content cigarettes, with and without nicotine replacement, in smokers with schizophrenia and controls.
    AhnAllen CG; Bidwell LC; Tidey JW
    Nicotine Tob Res; 2015 May; 17(5):510-4. PubMed ID: 25143294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes.
    Haughey HM; Marshall E; Schacht JP; Louis A; Hutchison KE
    Addiction; 2008 Oct; 103(10):1678-86. PubMed ID: 18705688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intolerance for smoking abstinence among nicotine-deprived, treatment-seeking smokers.
    Germeroth LJ; Baker NL; Saladin ME
    Addict Behav; 2018 Sep; 84():13-19. PubMed ID: 29597136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cannabinoid receptor 1: 5' exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse.
    Zhang PW; Ishiguro H; Ohtsuki T; Hess J; Carillo F; Walther D; Onaivi ES; Arinami T; Uhl GR
    Mol Psychiatry; 2004 Oct; 9(10):916-31. PubMed ID: 15289816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute nicotine reinforcement, but not chronic tolerance, predicts withdrawal and relapse after quitting smoking.
    Perkins KA; Broge M; Gerlach D; Sanders M; Grobe JE; Cherry C; Wilson AS
    Health Psychol; 2002 Jul; 21(4):332-9. PubMed ID: 12090675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CB
    Saravia R; Flores Á; Plaza-Zabala A; Busquets-Garcia A; Pastor A; de la Torre R; Di Marzo V; Marsicano G; Ozaita A; Maldonado R; Berrendero F
    Biol Psychiatry; 2017 Apr; 81(7):625-634. PubMed ID: 27737762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients.
    De Ruyck K; Nackaerts K; Beels L; Werbrouck J; De Volder A; Meysman M; Salhi B; Van Meerbeeck J; Thierens H
    Pharmacogenomics; 2010 Aug; 11(8):1053-63. PubMed ID: 20712524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment.
    Piper ME; Cook JW; Schlam TR; Jorenby DE; Baker TB
    Addiction; 2011 Feb; 106(2):418-27. PubMed ID: 20973856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled study of the kappa opioid receptor antagonist, CERC-501, in a human laboratory model of smoking behavior.
    Jones JD; Babalonis S; Marcus R; Vince B; Kelsh D; Lofwall MR; Fraser H; Paterson B; Martinez S; Martinez DM; Nunes EV; Walsh SL; Comer SD
    Addict Biol; 2020 Jul; 25(4):e12799. PubMed ID: 31240842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.